News
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Baird analyst Eric Coldwell maintained Quest Diagnostics with an Outperform rating and raised the price target from $191 to $194. Evercore ISI Group analyst Elizabeth Anderson maintained the stock with an In-Line rating and raised the price target from $175 to $180.
Investor Day to be held in New York on March ... Write to [email protected] Quest Diagnostics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Participating in Investor Day Advance registration is required. To register for the event, please go to: Quest Diagnostics 2025 Investor Day Registration. A live webcast of the event will ...
Investor's Business Daily on MSN1d
'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid ReportQuest Diagnostics stock remains a "safe haven," an analyst said Tuesday after the company topped first-quarter expectations.
Quest Diagnostics Inc.'s stock fell 3.6% early ... products and services to both investment professionals and individual investors. These products and services are usually sold through license ...
We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback